43. Hu C, Tkebuchava T. Health in All Laws: a better strategy
for global health. J Evidence-Based Med 2022;15:10-4.
44. Rayes J , Brill A. Hot under the clot:
venous thrombogenesis is an inflammatory process. Blood
2024;144:477-89.
45. Verma D, Kumar R, Pereira RS, et al. Vitamin K antagonism
impairs the bone marrow microenvironment and hematopoiesis. Blood
2019;134:227-38.
46. Caiado F , Kovtonyuk LV, Gonullu NG, Fullin J, Boettcher
S, Manz MG. Aging drives Tet2+/-
clonal hematopoiesis via IL-1 signaling. Blood 2023;141:886-903.
47. Caiado F , Manz MG. IL-1 in aging and
pathologies of hematopoietic stem cells. Blood 2024;144:368-77.
48. Hu, C. Emergency Protective Measures and Strategies of COVID-19:
From Lifestyle to Traditional Chinese Medicine. Clin Complement Med
Pharmacol 2023;3:100089.
49. Hu C, Tkebuchava T, Wu Q. A Novel Comprehensive Program Combining
Optimal Medical Treatment with Lifestyle Modification for Type 2
Diabetes. Cardiovasc Sci 2024;1:10004.
https://doi.org/10.35534/cvs.2024.10004
50. Bunne C, Roohani Y, Rosen Y, Gupta A, Zhang X, Roed M, Alexandrov T,
AlQuraishi M, Brennan P, Burkhardt DB, Califano A, Cool J, Dernburg AF,
Ewing K, Fox EB, Haury M, Herr AE, Horvitz E, Hsu PD, Jain V, Johnson
GR, Kalil T, Kelley DR, Kelley SO, Kreshuk A, Mitchison T, Otte S,
Shendure J, Sofroniew NJ, Theis F, Theodoris CV, Upadhyayula S, Valer M,
Wang B, Xing E, Yeung-Levy S, Zitnik M, Karaletsos T, Regev A, Lundberg
E, Leskovec J, Quake SR.
How to build the
virtual cell with artificial intelligence: Priorities and
opportunities. Cell 2024;187(25):7045-7063.
Table 1. The “magic polypill” or E(e)SEEDi as a
“super-vaccine” and a “super-therapy” for human diseases.